Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2001 6
2002 22
2003 15
2004 13
2005 13
2006 23
2007 30
2008 36
2009 25
2010 26
2011 31
2012 28
2013 33
2014 28
2015 24
2016 25
2017 21
2018 22
2019 27
2020 35
2021 21
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 18287255

441 results
Results by year
Filters applied: . Clear all
Page 1
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.
Canaud B, Mingardi G, Braun J, Aljama P, Kerr PG, Locatelli F, Villa G, Van Vlem B, McMahon AW, Kerloëguen C, Beyer U; STRIATA Study Investigators. Canaud B, et al. Nephrol Dial Transplant. 2008 Nov;23(11):3654-61. doi: 10.1093/ndt/gfn320. Epub 2008 Jun 27. Nephrol Dial Transplant. 2008. PMID: 18586762 Free PMC article. Clinical Trial.
Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U; PROTOS Study Investigators. Sulowicz W, et al. Clin J Am Soc Nephrol. 2007 Jul;2(4):637-46. doi: 10.2215/CJN.03631006. Epub 2007 May 23. Clin J Am Soc Nephrol. 2007. PMID: 17699476 Free article. Clinical Trial.
441 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page